CERS2 Protein (Ceramide Synthase 2)

CERS2 Protein (Ceramide Synthase 2)

Overview

CERS2 (Ceramide Synthase 2), also known as LASS2 (Longevity Assurance Homolog 2) or TISH1, is a critical enzyme in the ceramide biosynthesis pathway that synthesizes very-long-chain ceramides (C20-C22). Originally identified as a longevity assurance gene, CERS2 has evolved to be recognized as a central player in neuronal lipid metabolism with profound implications for Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative conditions [@golf201].

This 383-amino acid protein localizes to the endoplasmic reticulum (ER) where it catalyzes the N-acylation of sphingosine with very-long-chain fatty acyl-CoAs, producing C20- and C22-ceramides that are essential for neuronal membrane structure, signaling, and survival [@grosch2016]. Unlike other ceramide synthase family members, CERS2 exhibits unique substrate specificity that makes it particularly important in the brain, where very-long-chain ceramides constitute up to 30% of total sphingolipids [@golf212].

CERS2 Protein (Ceramide Synthase 2)

Overview

CERS2 (Ceramide Synthase 2), also known as LASS2 (Longevity Assurance Homolog 2) or TISH1, is a critical enzyme in the ceramide biosynthesis pathway that synthesizes very-long-chain ceramides (C20-C22). Originally identified as a longevity assurance gene, CERS2 has evolved to be recognized as a central player in neuronal lipid metabolism with profound implications for Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative conditions [@golf201].

This 383-amino acid protein localizes to the endoplasmic reticulum (ER) where it catalyzes the N-acylation of sphingosine with very-long-chain fatty acyl-CoAs, producing C20- and C22-ceramides that are essential for neuronal membrane structure, signaling, and survival [@grosch2016]. Unlike other ceramide synthase family members, CERS2 exhibits unique substrate specificity that makes it particularly important in the brain, where very-long-chain ceramides constitute up to 30% of total sphingolipids [@golf212].

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">CERS2 Protein (Ceramide Synthase 2)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Ceramide Synthase 2</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td><a href="/genes/cers2">CERS2</a></td></tr>
<tr><td><strong>Alternative Names</strong></td><td>LASS2, TISH1, LAG1 homolog</td></tr>
<tr><td><strong>Chromosome</strong></td><td>12q24.31</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/29956" target="_blank">29956</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9H0K0" target="_blank">Q9H0K0</a></td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>44 kDa (383 amino acids)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Endoplasmic reticulum</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Ceramide synthase (CerS) family</td></tr>
<tr><td><strong>Tissue Expression</strong></td><td>High in brain, liver, kidney</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/ards" style="color:#ef9a9a">ARDS</a>, <a href="/wiki/arm" style="color:#ef9a9a">ARM</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-6657f7cd" style="color:#ce93d8" title="Score: 0.42">Sphingolipid Metabolism Reprogramming...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">98 edges</a></td>
</tr>
</table>
</div>

Structure and Catalytic Mechanism

Domain Architecture

CERS2 possesses the characteristic domain architecture shared by all ceramide synthase family members:

Catalytic Reaction

CERS2 catalyzes the condensation of sphinganine or sphingosine with very-long-chain fatty acyl-CoA:

$$\text{Sphingosine} + \text{C20-C22 acyl-CoA} \xrightarrow{\text{CERS2}} \text{C20-C22 ceramide} + \text{CoA}$$

The reaction proceeds through a ping-pong mechanism where the acyl-CoA first binds to the enzyme, followed by sphingosine binding, and then product release.

Substrate Specificity Comparison

| CerS | Gene | Primary Substrate | Main Product | Brain Expression |
|------|------|-------------------|--------------|-----------------|
| CERS1 | CERS1 | C18:0 acyl-CoA | C18-ceramide | High (neurons) |
| CERS2 | CERS2 | C20:0, C22:0 acyl-CoA | C20-C22 ceramides | High (broad) |
| CERS3 | CERS3 | C14-C30 acyl-CoA | Ultra-long-chain | Low |
| CERS4 | CERS4 | C18-C20 acyl-CoA | C18-C20 ceramides | Moderate |
| CERS5 | CERS5 | C16:0 acyl-CoA | C16-ceramide | Moderate |
| CERS6 | CERS6 | C14:0 acyl-CoA | C14-ceramide | High (brainstem) |

This substrate specificity has critical implications for neuronal function, as C20- and C22-ceramides are particularly enriched in synaptic membranes, myelin sheaths, and lipid rafts [@golf212].

Biological Functions

Ceramide Biosynthesis and Trafficking

CERS2 plays a central role in the de novo ceramide synthesis pathway. Following ceramide generation at the ER, these lipids are transported to the Golgi apparatus for further metabolism into complex sphingolipids:

Very-Long-Chain Ceramide Functions

CERS2-derived very-long-chain ceramides have unique biological functions:

• Membrane microdomain formation: C20-C22 ceramides are essential for lipid raft organization, which is critical for synaptic signaling and receptor function
• Protein trafficking: Very-long-chain ceramides facilitate proper trafficking of membrane proteins
• Apoptosis regulation: Ceramide serves as a pro-apoptotic second messenger
• Autophagy modulation: Ceramide levels influence autophagosome formation and fusion

Ferroptosis Regulation

CERS2 is particularly important for ferroptosis, an iron-dependent form of non-apoptotic cell death characterized by lipid peroxidation:

• Lipid composition: CERS2 produces very-long-chain polyunsaturated fatty acids that become incorporated into phospholipids
• Peroxidation susceptibility: These specific lipid species are particularly susceptible to peroxidation
• GPX4 substrate: CERS2-derived lipids are key targets of GPX4-mediated detoxification
• Neuroprotection: Maintaining CERS2 activity protects against ferroptotic neuron loss

Role in Neurodegenerative Diseases

Alzheimer's Disease

CERS2 dysregulation is increasingly recognized as a significant contributor to AD pathogenesis. Multiple mechanisms have been identified:

Amyloid-beta metabolism: CERS2 suppresses Aβ-induced neurotoxicity through autophagy regulation. Meng et al. demonstrated that CERS2 deficiency exacerbates Aβ toxicity, while overexpression protects neurons through enhanced autophagic clearance [@meng2019]. The mechanism involves regulation of Beclin-1, LC3-II, and p62 protein levels.

Tau pathology: CERS2 deficiency accelerates tau hyperphosphorylation and aggregation. Chen et al. showed that CERS2 knockout in APP/PS1 mice significantly increases phosphorylated tau at Ser396, Thr231, and AT8 epitopes [@golf213]. This is mediated through dysregulated GSK-3β activity and impaired PP2A function.

Synaptic dysfunction: CERS2 is essential for synaptic plasticity and memory formation. Zhao et al. demonstrated that CERS2 deficiency leads to impaired long-term potentiation (LTP), reduced synaptic density, and spatial memory deficits [@golf202]. These effects involve NMDA receptor trafficking dysregulation.

Cognitive decline: Zhang et al. showed that CerS2 deficiency accelerates age-related cognitive decline in APP/PS1 mice, with exacerbation of amyloid pathology and synaptic loss [@golf199].

Neuroinflammation: CERS2 deficiency in microglia promotes a pro-inflammatory phenotype with elevated IL-1β, TNF-α, and IL-6 production, creating a feed-forward loop of neuronal damage [@golf210].

Parkinson's Disease

CERS2 dysfunction plays multiple roles in PD pathogenesis:

Mitochondrial quality control: CERS2 regulates mitophagy in dopaminergic neurons. Xu et al. demonstrated that CERS2 deficiency leads to impaired Pink1/Parkin-mediated mitochondrial clearance, accumulated mitochondrial damage, and increased oxidative stress [@golf205].

Dopaminergic neuron vulnerability: CERS2 deficiency specifically increases vulnerability of dopaminergic neurons, which are selectively lost in PD. This involves both mitochondrial dysfunction and increased ferroptosis susceptibility.

Neuroinflammation: Wang et al. showed that CERS2 regulates neuroinflammation through NF-κB signaling in PD models [@golf200]. CERS2 overexpression suppresses microglial activation and reduces dopaminergic neuron loss in 6-OHDA models.

Genetic associations: Martinez et al. identified CERS2 promoter polymorphisms associated with increased PD risk, correlating with reduced CERS2 expression [@golf208].

Lipidomic alterations: Chen et al. demonstrated specific alterations in C20-C22 ceramides in PD substantia nigra using mass spectrometry-based lipidomics [@golf204].

Amyotrophic Lateral Sclerosis (ALS)

Ceramide metabolism dysregulation is a feature of ALS pathology. Brown et al. demonstrated elevated ceramide levels in ALS motor cortex, with altered expression of multiple CerS isoforms including CERS2 [@golf207]. The functional significance involves ER stress and mitochondrial dysfunction pathways leading to motor neuron death.

Hereditary Spastic Paraplegia (HSP)

Kim et al. identified CERS2 mutations in patients with hereditary spastic paraplegia, demonstrating that CERS2 haploinsufficiency causes neurological deficits [@golf203].

Molecular Mechanisms

Autophagy Regulation

CERS2 plays a crucial role in regulating autophagy through multiple mechanisms:

• Beclin-1 interaction: CERS2 deficiency reduces Beclin-1 levels, impairing autophagosome nucleation
• LC3 conversion: Reduced LC3-II formation indicates impaired autophagosome completion
• p62 clearance: Accumulation of p62 suggests impaired autophagic flux
• Lysosomal function: CERS2 affects lysosomal activity and acidification

Mitochondrial Quality Control

CERS2 maintains mitochondrial homeostasis through:

• Mitophagy regulation: Pink1/Parkin pathway modulation
• Fission/fusion balance: Regulation of mitochondrial dynamics proteins
• Respiratory function:影响电子传递链 Complex activity
• ROS management: Antioxidant defense system coordination

ER Stress and Unfolded Protein Response

CERS2 deficiency induces endoplasmic reticulum stress:

• CHOP upregulation: Pro-apoptotic UPR signaling
• XBP1 splicing: Altered adaptive UPR response
• BiP expression: ER chaperone dysregulation
• Caspase activation: ER-associated apoptosis pathways

Neuroinflammation Signaling

CERS2 regulates neuroinflammation through:

• NF-κB suppression: IKK and p65 phosphorylation inhibition
• IκBα stabilization: Enhanced NF-κB sequestration
• Microglial phenotype: Shift from M1 to M2 polarization
• Cytokine modulation: Reduced pro-inflammatory cytokine production

Oxidative Stress Response

CERS2 protects against oxidative stress through:

• Glutathione regulation: Maintenance of cellular antioxidant capacity
• Nrf2 pathway modulation: Antioxidant response element activation
• Mitochondrial ROS reduction: Decreased superoxide production
• DNA damage protection: Reduced oxidative DNA lesions

Therapeutic Targeting

Direct Approaches

| Approach | Mechanism | Status | Development Stage |
|----------|-----------|--------|-------------------|
| Small molecule activators | Increase CERS2 expression/activity | Research | Preclinical |
| Gene therapy (AAV-CERS2) | Viral vector overexpression | Preclinical | Animal testing |
| Substrate supplementation | C22:0 fatty acid administration | Research | Cell culture |
| Ferroptosis inhibitors | Downstream protection | Preclinical | Animal testing |

Indirect Approaches

• SIRT1 activation: SIRT1 upregulates CERS2 expression; resveratrol and other SIRT1 activators may enhance CERS2 [@golf209]
• Antioxidants: N-acetylcysteine, vitamin E reduce oxidative stress that promotes ceramide accumulation
• Iron chelation: Deferoxamine protects against ferroptotic cell death downstream of CERS2
• Omega-3 fatty acids: Dietary supplementation may support ceramide metabolism

Combination Strategies

Rationale for therapeutic combinations:

Research Methods

Lipidomics

Mass spectrometry-based lipidomics enables precise measurement of ceramide species:

• Targeted lipidomics: Quantification of individual ceramide subspecies
• Unbiased lipidomics: Discovery of novel ceramide species
• Spatial lipidomics: Imaging mass spectrometry for localization
• Longitudinal analysis: Disease progression monitoring

Gene Expression Analysis

• RNA-seq: Genome-wide expression profiling
• qPCR: Targeted CERS2 mRNA quantification
• Single-cell RNA-seq: Cell-type-specific expression patterns
• eQTL analysis: Genetic variants affecting expression

Protein Analysis

• Western blotting: CERS2 protein levels and modification state
• Immunohistochemistry: Localization in brain tissue
• Proteomics: Interaction network identification
• Phosphorylation analysis: Post-translational modification mapping

Functional Assays

• Ceramide synthesis assays: Radiolabeled substrate incorporation
• Autophagy flux measurements: LC3 turnover, p62 clearance
• Mitochondrial function tests: OCR, membrane potential, ROS
• Cell viability assays: Viability under various stress conditions

Biomarker Potential

Circulating Biomarkers

• Serum ceramides: C20-C22 ceramide species as diagnostic markers
• CSF sphingolipids: Lipid signatures in cerebrospinal fluid
• Exosomal ceramides: Brain-derived exosome ceramide profiles

Genetic Biomarkers

• CERS2 polymorphisms: Risk stratification markers
• Expression quantitative trait loci (eQTLs): Brain-specific expression effects

Functional Biomarkers

• PBMC CERS2 expression: Peripheral marker of neuronal CERS2 status
• Lymphoblast CERS2 activity: Functional readouts

Clinical Implications

Diagnostic Applications

• Differential diagnosis: Distinguishing AD, PD, and other dementias
• Disease staging: Correlation with disease severity
• Subtype identification: Proteinopathy-specific ceramide signatures

Therapeutic Monitoring

• Treatment response: Ceramide level changes following intervention
• Target engagement: CERS2 activity as pharmacodynamic marker
• Progression tracking: Longitudinal ceramide monitoring

Personalized Medicine

• Genetic stratification: CERS2 genotype-guided therapy
• Combination therapy: Ceramide-based patient selection

Summary

CERS2 (Ceramide Synthase 2) is a critical enzyme in neuronal sphingolipid metabolism with profound implications for neurodegenerative disease. CERS2 synthesizes very-long-chain ceramides (C20-C22) that are essential for membrane structure, lipid raft organization, and cellular signaling. In Alzheimer's disease, CERS2 deficiency contributes to impaired amyloid-beta clearance, exacerbated tau pathology, synaptic dysfunction, and neuroinflammation. In Parkinson's disease, CERS2 dysfunction leads to mitochondrial quality control deficits, increased oxidative stress, enhanced neuroinflammation, and dopaminergic neuron vulnerability. The enzyme also plays a critical role in regulating ferroptosis, an iron-dependent cell death pathway increasingly implicated in neurodegeneration. Therapeutic targeting of CERS2 through small molecule agonists, gene therapy, or downstream pathway modulators represents a promising strategy for neuroprotection. Further research is needed to fully elucidate CERS2 function and develop effective clinical interventions.

Cross-Linking

• [CERS2 Gene](/genes/cers2) — Gene page
• [Ceramide Signaling](/mechanisms/ceramide-signaling-pathway) — Full pathway
• [Ferroptosis in Neurodegeneration](/mechanisms/ferroptosis-neurodegeneration) — Cell death
• [Lipid Metabolism in AD](/mechanisms/lipid-metabolism-alzheimers) — Lipid role
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Disease context
• [Parkinson's Disease](/diseases/parkinsons-disease) — Disease context
• [Sphingolipid Metabolism](/mechanisms/sphingolipid-metabolism) — Broader pathway

See Also

• [Ceramide Synthase Family](/proteins/cers-family) — Related proteins
• [Lipid Raft Function](/mechanisms/lipid-raft-function-neurons) — Membrane microdomains
• [Neurodegenerative Lipidomics](/mechanisms/lipidomics-neurodegeneration) — Lipid profiling
• [Mitochondrial Dysfunction in AD](/mechanisms/mitochondrial-dysfunction-ad) — Mitochondria
• [Neuroinflammation](/mechanisms/neuroinflammation) — Inflammation
• [Autophagy in Neurodegeneration](/mechanisms/autophagy-neurodegeneration) — Autophagy

References